Stocks · News reference
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.16) per share. This is a 25.52 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Addex Therapeutics (NASDAQ:ADXN) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time
Companies Reporting Before The Bell • Kandi Technologies Gr (NASDAQ:KNDI) is likely to report earnings for its first quarter. • Inventiva (NASDAQ:IVA) is expected to report quarterly loss at $0.20 per share on revenue
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.52) per share. This is a 47.59 percent increase over losses of $(2.90) per share from the same period last year. The company reported $12.650 thousand